董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Chaim Indig | 男 | Chief Executive Officer and Director | 47 | 807.77万美元 | 182.32 | 2026-06-24 |
| Mark Smith | 男 | Independent Director | 74 | 23.50万美元 | 5.73 | 2026-06-24 |
| Ramin Sayar | 男 | Independent Director and Independent Chairman | 53 | 23.50万美元 | 2.67 | 2026-06-24 |
| Lisa Egbuonu Davis | 女 | Independent Director | 67 | 23.00万美元 | 1.21 | 2026-06-24 |
| Jon Kessler | 男 | Independent Director | 58 | 未披露 | 未持股 | 2026-06-24 |
| Lainie Goldstein | 女 | Independent Director | 58 | 22.49万美元 | 1.13 | 2026-06-24 |
| Gillian Munson | 女 | Independent Director | 55 | 24.74万美元 | 5.23 | 2026-06-24 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Chaim Indig | 男 | Chief Executive Officer and Director | 47 | 807.77万美元 | 182.32 | 2026-06-24 |
| Evan Roberts | 男 | President, Provider Solutions | 47 | 365.89万美元 | 72.33 | 2026-06-24 |
| David Linetsky | 男 | President, Network Solutions | 46 | 362.72万美元 | 9.56 | 2026-06-24 |
| Amy Beth VanDuyn | 女 | Senior Vice President of Human Resources | 53 | 未披露 | 未持股 | 2026-06-24 |
| Balaji Gandhi | 男 | Chief Financial Officer | 52 | 365.89万美元 | 2.51 | 2026-06-24 |
| Allison Hoffman | 女 | General Counsel and Secretary | 55 | 264.53万美元 | 4.74 | 2026-06-24 |
董事简历
中英对照 | 中文 | 英文- Chaim Indig
-
自2005年1月成立以来，Chaim Indig一直担任我们的首席执行官和董事会成员。在共同创立Phreesia之前，Indig先生领导分析软件公司SpotFire，Inc.成功引入药品营销领域。英迪格曾入围2011年安永企业家奖（Ernst&Young&；S&；8220；Entrepreneur of the Year&；8221；），并作为梦百合创新者入选《斯坦福社会创新评论》（Stanford Social Innovation Review）。
Chaim Indig,has helped shape the healthcare experience and improve outcomes for patients, providers and staff. Under his leadership, Phreesia has established a broad national footprint and earned accolades for the Company's role in helping to make care more efficient and patient-centered. He also led Phreesia through its initial public offering in 2019 and was named one of The Software Report's Top 50 SaaS CEOs in 2021, 2022 and 2023. Prior to co-founding Phreesia, Mr. Indig spearheaded the introduction of the analytics software company, Spotfire, Inc., into the pharmaceutical marketing space. - 自2005年1月成立以来，Chaim Indig一直担任我们的首席执行官和董事会成员。在共同创立Phreesia之前，Indig先生领导分析软件公司SpotFire，Inc.成功引入药品营销领域。英迪格曾入围2011年安永企业家奖（Ernst&Young&；S&；8220；Entrepreneur of the Year&；8221；），并作为梦百合创新者入选《斯坦福社会创新评论》（Stanford Social Innovation Review）。
- Chaim Indig,has helped shape the healthcare experience and improve outcomes for patients, providers and staff. Under his leadership, Phreesia has established a broad national footprint and earned accolades for the Company's role in helping to make care more efficient and patient-centered. He also led Phreesia through its initial public offering in 2019 and was named one of The Software Report's Top 50 SaaS CEOs in 2021, 2022 and 2023. Prior to co-founding Phreesia, Mr. Indig spearheaded the introduction of the analytics software company, Spotfire, Inc., into the pharmaceutical marketing space.
- Mark Smith
-
Mark Smith自2018年10月以来一直担任我们的董事会成员。Smith博士目前是University of California at San Francisco临床医学教授。2015年至2019年，他担任医疗保健支付学习和行动网络指导委员会联合主席。在此之前，从1996年到2013年，史密斯博士是加州梦百合基金会（California Foundation，Inc.）的创始总裁兼前首席执行官，该基金会是一家专注于改善个人健康的慈善组织。Smith博士担任Teladoc Health，Inc.、英联邦基金、梦百合改善研究所、Prealize和Concerto梦百合，Inc.的董事会成员。史密斯博士在马萨诸塞州剑桥市的哈佛学院获得非裔美国人研究的学士学位，在北卡罗来纳州教堂山的北卡罗来纳大学获得医学博士学位，在宾夕法尼亚州费城的宾夕法尼亚大学获得梦百合管理的工商管理硕士学位。
Mark Smith,was the founding President and former Chief Executive Officer of the California Health Care Foundation, Inc., a philanthropic organization focused on improving the health of individuals, from 1996 to 2013. Dr. Smith serves as a member of the board of directors of Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Teladoc Health, Inc. (NYSE: TDOC) and Prealize Health. Dr. Smith earned his B.A. degree in Afro-American Studies from Harvard College, his M.D. from the University of North Carolina at Chapel Hill, and his M.B.A. in Healthcare Administration from the Wharton School at the University of Pennsylvania. - Mark Smith自2018年10月以来一直担任我们的董事会成员。Smith博士目前是University of California at San Francisco临床医学教授。2015年至2019年，他担任医疗保健支付学习和行动网络指导委员会联合主席。在此之前，从1996年到2013年，史密斯博士是加州梦百合基金会（California Foundation，Inc.）的创始总裁兼前首席执行官，该基金会是一家专注于改善个人健康的慈善组织。Smith博士担任Teladoc Health，Inc.、英联邦基金、梦百合改善研究所、Prealize和Concerto梦百合，Inc.的董事会成员。史密斯博士在马萨诸塞州剑桥市的哈佛学院获得非裔美国人研究的学士学位，在北卡罗来纳州教堂山的北卡罗来纳大学获得医学博士学位，在宾夕法尼亚州费城的宾夕法尼亚大学获得梦百合管理的工商管理硕士学位。
- Mark Smith,was the founding President and former Chief Executive Officer of the California Health Care Foundation, Inc., a philanthropic organization focused on improving the health of individuals, from 1996 to 2013. Dr. Smith serves as a member of the board of directors of Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Teladoc Health, Inc. (NYSE: TDOC) and Prealize Health. Dr. Smith earned his B.A. degree in Afro-American Studies from Harvard College, his M.D. from the University of North Carolina at Chapel Hill, and his M.B.A. in Healthcare Administration from the Wharton School at the University of Pennsylvania.
- Ramin Sayar
-
Ramin Sayar，自2021年10月起担任Phreesia, Inc.董事会成员。Sayar先生是Sumo Logic, Inc.的首席执行官和董事会成员，Sumo Logic公司是一家软件公司，他自2014年12月以来一直在该公司任职。2010年4月至2014年12月，Sayar先生在软件虚拟化公司VMware，Inc.担任云管理业务部高级副总裁兼总经理。2006年11月至2010年4月，Sayar先生在软件开发公司惠普软件技术有限公司担任产品和战略副总裁。萨亚尔拥有加州大学圣巴巴拉分校的历史学学士学位和圣何塞州立大学的工商管理硕士学位。
Ramin Sayar,served as the President and Chief Executive Officer and a member of the board of directors of Sumo Logic, Inc., a cyber security and data analytics software company. From April 2010 to December 2014, Mr. Sayar served as Senior Vice President and General Manager, Cloud Management Business Unit at VMware, Inc., a software virtualization company. From November 2006 to April 2010, Mr. Sayar served as Vice President of Products and Strategy at HP Software Technology Pvt. Ltd., a software development company. Mr. Sayar holds a B.A. in History from the University of California, Santa Barbara and an M.B.A. from San Jose State University. - Ramin Sayar，自2021年10月起担任Phreesia, Inc.董事会成员。Sayar先生是Sumo Logic, Inc.的首席执行官和董事会成员，Sumo Logic公司是一家软件公司，他自2014年12月以来一直在该公司任职。2010年4月至2014年12月，Sayar先生在软件虚拟化公司VMware，Inc.担任云管理业务部高级副总裁兼总经理。2006年11月至2010年4月，Sayar先生在软件开发公司惠普软件技术有限公司担任产品和战略副总裁。萨亚尔拥有加州大学圣巴巴拉分校的历史学学士学位和圣何塞州立大学的工商管理硕士学位。
- Ramin Sayar,served as the President and Chief Executive Officer and a member of the board of directors of Sumo Logic, Inc., a cyber security and data analytics software company. From April 2010 to December 2014, Mr. Sayar served as Senior Vice President and General Manager, Cloud Management Business Unit at VMware, Inc., a software virtualization company. From November 2006 to April 2010, Mr. Sayar served as Vice President of Products and Strategy at HP Software Technology Pvt. Ltd., a software development company. Mr. Sayar holds a B.A. in History from the University of California, Santa Barbara and an M.B.A. from San Jose State University.
- Lisa Egbuonu Davis
-
Lisa Egbuonu Davis，曾担任DH Diagnostics，LLC的医疗创新副总裁，DH Diagnostics，LLC是丹纳赫公司（“丹纳赫”）（纽约证券交易所代码：丹纳赫）的附属公司，在那里她提供医疗建议，以影响TERM3诊断平台业务的研究、合作伙伴关系和投资战略。也在此期间，她曾多次担任某些丹纳赫子公司的临时首席医疗官。2015年至2019年，Egbuonu-Davis博士在赛诺菲公司（纳斯达克股票代码：SNY）担任全球以患者为中心的结果和解决方案副总裁。Egbuonu-Davis博士目前担任Omega Healthcare投资者（NYSE：OHI）的董事会成员，这是一家专注于熟练护理设施的公共持有的房地产投资信托基金，以及AVNS的公共持有的医疗技术公司Avanos Medical（NYSE：TERM3），该公司生产用于消化系统健康和疼痛的设备。Egbuonu-Davis博士还在约翰霍普金斯大学医学董事会和约翰霍普金斯大学教育学院国家咨询委员会任职。她拥有宾夕法尼亚大学沃顿商学院的医疗保健管理工商管理硕士学位，并拥有约翰霍普金斯大学的医学博士和公共卫生（流行病学）硕士学位。她获得儿科委员会认证。
Lisa Egbuonu Davis,served as Vice President, Medical Innovations for DH Diagnostics, LLC, an affiliate of Danaher Corporation ("Danaher") (NYSE: DHR), where she provided medical advice to influence research, partnership and investment strategy across Danaher's diagnostic platform businesses. Also during this period, she served at various times as Interim Chief Medical Officer for certain Danaher subsidiaries. From 2015 to 2019, Dr. Egbuonu-Davis served as Vice President, Global Patient Centered Outcomes and Solutions at Sanofi, Inc. (NASDAQ: SNY). Dr. Egbuonu-Davis currently serves on the boards of Omega Healthcare Investors (NYSE:OHI) a publicly held real estate investment trust focusing on skilled nursing facilities and Avanos Medical (NYSE: AVNS), a publicly held medical technology company that makes equipment for digestive health and pain. Dr. Egbuonu-Davis also serves on the Johns Hopkins Medicine Board of Trustees and the National Advisory Council for the Johns Hopkins University School of Education. She holds a Master of Business Administration in Health Care Management from The Wharton School of the University of Pennsylvania, and she holds Doctor of Medicine and Master of Public Health (epidemiology) degrees from Johns Hopkins University. She is board certified in pediatrics. - Lisa Egbuonu Davis，曾担任DH Diagnostics，LLC的医疗创新副总裁，DH Diagnostics，LLC是丹纳赫公司（“丹纳赫”）（纽约证券交易所代码：丹纳赫）的附属公司，在那里她提供医疗建议，以影响TERM3诊断平台业务的研究、合作伙伴关系和投资战略。也在此期间，她曾多次担任某些丹纳赫子公司的临时首席医疗官。2015年至2019年，Egbuonu-Davis博士在赛诺菲公司（纳斯达克股票代码：SNY）担任全球以患者为中心的结果和解决方案副总裁。Egbuonu-Davis博士目前担任Omega Healthcare投资者（NYSE：OHI）的董事会成员，这是一家专注于熟练护理设施的公共持有的房地产投资信托基金，以及AVNS的公共持有的医疗技术公司Avanos Medical（NYSE：TERM3），该公司生产用于消化系统健康和疼痛的设备。Egbuonu-Davis博士还在约翰霍普金斯大学医学董事会和约翰霍普金斯大学教育学院国家咨询委员会任职。她拥有宾夕法尼亚大学沃顿商学院的医疗保健管理工商管理硕士学位，并拥有约翰霍普金斯大学的医学博士和公共卫生（流行病学）硕士学位。她获得儿科委员会认证。
- Lisa Egbuonu Davis,served as Vice President, Medical Innovations for DH Diagnostics, LLC, an affiliate of Danaher Corporation ("Danaher") (NYSE: DHR), where she provided medical advice to influence research, partnership and investment strategy across Danaher's diagnostic platform businesses. Also during this period, she served at various times as Interim Chief Medical Officer for certain Danaher subsidiaries. From 2015 to 2019, Dr. Egbuonu-Davis served as Vice President, Global Patient Centered Outcomes and Solutions at Sanofi, Inc. (NASDAQ: SNY). Dr. Egbuonu-Davis currently serves on the boards of Omega Healthcare Investors (NYSE:OHI) a publicly held real estate investment trust focusing on skilled nursing facilities and Avanos Medical (NYSE: AVNS), a publicly held medical technology company that makes equipment for digestive health and pain. Dr. Egbuonu-Davis also serves on the Johns Hopkins Medicine Board of Trustees and the National Advisory Council for the Johns Hopkins University School of Education. She holds a Master of Business Administration in Health Care Management from The Wharton School of the University of Pennsylvania, and she holds Doctor of Medicine and Master of Public Health (epidemiology) degrees from Johns Hopkins University. She is board certified in pediatrics.
- Jon Kessler
-
Jon Kessler在其职业生涯的大部分时间里，都在领导和扩展医疗保健金融服务公司，并深切关注通过技术创新推动股东价值创造。
Jon Kessler,has spent the majority of his career leading and scaling healthcare financial services companies, with a deep focus on driving shareholder value creation through technological innovation. - Jon Kessler在其职业生涯的大部分时间里，都在领导和扩展医疗保健金融服务公司，并深切关注通过技术创新推动股东价值创造。
- Jon Kessler,has spent the majority of his career leading and scaling healthcare financial services companies, with a deep focus on driving shareholder value creation through technological innovation.
- Lainie Goldstein
-
Lainie Goldstein，2007年6月起，她担任公司首席财务官。她还监督投资关系。2003年11月至2007年6月，她担任公司财政高级副总裁。她在软件、娱乐、零售和服装行业有20多年的财政和商业经验，包括13年监督上市公司财政状况的经历。2003年11月加入公司之前，她在服装公司Nautica Enterprises, Inc.担任7年的财政职位，最近担任财政与商业发展副总裁。她是一名注册会计师。1990至加入Nautica Enterprises, Inc.， 她在Grant Thornton LLP.的审计与重组部门担任职位。
Lainie Goldstein has been Chief Financial Officer of the Company since June 2007, and is responsible for overseeing Finance, Investor Relations and Corporate Communications. Ms. Goldstein previously served as the Company's Senior Vice President of Finance from November 2003. Ms. Goldstein also serves as a director and member of the audit committee of Phreesia, Inc. - Lainie Goldstein，2007年6月起，她担任公司首席财务官。她还监督投资关系。2003年11月至2007年6月，她担任公司财政高级副总裁。她在软件、娱乐、零售和服装行业有20多年的财政和商业经验，包括13年监督上市公司财政状况的经历。2003年11月加入公司之前，她在服装公司Nautica Enterprises, Inc.担任7年的财政职位，最近担任财政与商业发展副总裁。她是一名注册会计师。1990至加入Nautica Enterprises, Inc.， 她在Grant Thornton LLP.的审计与重组部门担任职位。
- Lainie Goldstein has been Chief Financial Officer of the Company since June 2007, and is responsible for overseeing Finance, Investor Relations and Corporate Communications. Ms. Goldstein previously served as the Company's Senior Vice President of Finance from November 2003. Ms. Goldstein also serves as a director and member of the audit committee of Phreesia, Inc.
- Gillian Munson
-
Gillian Munson，曾担任Phreesia, Inc.的成员。自2019年5月起担任董事会成员。Munson女士目前担任Vimeo, Inc.（视频托管、分享和服务平台）的首席财务官（2022年4月以来）。从2021年10月到2022年3月，Munson女士担任One Medical（会员制初级保健实践）的首席财务官特别顾问。在此之前，她曾担任Iora Health, Inc.（一家医疗保健公司）的首席财务官（从2020年12月到2021年9月出售）。Munson女士此前曾担任Union Square Ventures的合伙人。在此之前，她曾担任XO Group Inc. （the Knot Inc.的母公司）的首席财务官、财务主管和秘书（2013年至2019年）。Munson女士还曾担任Symbol Technologies, LLC的业务发展副总裁，Morgan Stanley的执行董事和高级股票分析师，Hambrecht & Quist的股票研究助理。她目前担任Duolingo, Inc.和the St. Regis Foundation的董事会成员，之前担任Monster Worldwide, Inc.的董事会成员。Munson女士获得The Colorado College的政治学和经济学学士学位。
Gillian Munson,was Chief Financial Officer of Iora Health, Inc. from December 2020 until its sale to One Medical in September 2021. Ms. Munson previously served as a Partner at Union Square Ventures. Prior to that, she served as Chief Financial Officer, Treasurer and Secretary of XO Group Inc., the parent company of The Knot Inc., from 2013 until 2019. Ms. Munson also held previous roles at Symbol Technologies, LLC, Morgan Stanley and Hambrecht & Quist. She currently serves on the board of directors of Duolingo, Inc. (NASDAQ: DUOL), the Southern Vermont Art Center and The St. Regis Foundation and previously served on the board of directors of Monster Worldwide, Inc. Ms. Munson earned her B.A. in Political Science and Economics from The Colorado College. - Gillian Munson，曾担任Phreesia, Inc.的成员。自2019年5月起担任董事会成员。Munson女士目前担任Vimeo, Inc.（视频托管、分享和服务平台）的首席财务官（2022年4月以来）。从2021年10月到2022年3月，Munson女士担任One Medical（会员制初级保健实践）的首席财务官特别顾问。在此之前，她曾担任Iora Health, Inc.（一家医疗保健公司）的首席财务官（从2020年12月到2021年9月出售）。Munson女士此前曾担任Union Square Ventures的合伙人。在此之前，她曾担任XO Group Inc. （the Knot Inc.的母公司）的首席财务官、财务主管和秘书（2013年至2019年）。Munson女士还曾担任Symbol Technologies, LLC的业务发展副总裁，Morgan Stanley的执行董事和高级股票分析师，Hambrecht & Quist的股票研究助理。她目前担任Duolingo, Inc.和the St. Regis Foundation的董事会成员，之前担任Monster Worldwide, Inc.的董事会成员。Munson女士获得The Colorado College的政治学和经济学学士学位。
- Gillian Munson,was Chief Financial Officer of Iora Health, Inc. from December 2020 until its sale to One Medical in September 2021. Ms. Munson previously served as a Partner at Union Square Ventures. Prior to that, she served as Chief Financial Officer, Treasurer and Secretary of XO Group Inc., the parent company of The Knot Inc., from 2013 until 2019. Ms. Munson also held previous roles at Symbol Technologies, LLC, Morgan Stanley and Hambrecht & Quist. She currently serves on the board of directors of Duolingo, Inc. (NASDAQ: DUOL), the Southern Vermont Art Center and The St. Regis Foundation and previously served on the board of directors of Monster Worldwide, Inc. Ms. Munson earned her B.A. in Political Science and Economics from The Colorado College.
高管简历
中英对照 | 中文 | 英文- Chaim Indig
自2005年1月成立以来，Chaim Indig一直担任我们的首席执行官和董事会成员。在共同创立Phreesia之前，Indig先生领导分析软件公司SpotFire，Inc.成功引入药品营销领域。英迪格曾入围2011年安永企业家奖（Ernst&Young&；S&；8220；Entrepreneur of the Year&；8221；），并作为梦百合创新者入选《斯坦福社会创新评论》（Stanford Social Innovation Review）。
Chaim Indig,has helped shape the healthcare experience and improve outcomes for patients, providers and staff. Under his leadership, Phreesia has established a broad national footprint and earned accolades for the Company's role in helping to make care more efficient and patient-centered. He also led Phreesia through its initial public offering in 2019 and was named one of The Software Report's Top 50 SaaS CEOs in 2021, 2022 and 2023. Prior to co-founding Phreesia, Mr. Indig spearheaded the introduction of the analytics software company, Spotfire, Inc., into the pharmaceutical marketing space.- 自2005年1月成立以来，Chaim Indig一直担任我们的首席执行官和董事会成员。在共同创立Phreesia之前，Indig先生领导分析软件公司SpotFire，Inc.成功引入药品营销领域。英迪格曾入围2011年安永企业家奖（Ernst&Young&；S&；8220；Entrepreneur of the Year&；8221；），并作为梦百合创新者入选《斯坦福社会创新评论》（Stanford Social Innovation Review）。
- Chaim Indig,has helped shape the healthcare experience and improve outcomes for patients, providers and staff. Under his leadership, Phreesia has established a broad national footprint and earned accolades for the Company's role in helping to make care more efficient and patient-centered. He also led Phreesia through its initial public offering in 2019 and was named one of The Software Report's Top 50 SaaS CEOs in 2021, 2022 and 2023. Prior to co-founding Phreesia, Mr. Indig spearheaded the introduction of the analytics software company, Spotfire, Inc., into the pharmaceutical marketing space.
- Evan Roberts
Evan Roberts自2019年1月起担任我们的首席运营官。罗伯茨先生曾于2012年1月至2019年1月担任客户解决方案Vice President，并于2005年1月成立至2012年1月担任首席技术官。在共同创立Phreesia之前，Roberts先生是Spotfire，Inc.的高级销售工程师，在那里他成功地领导了分析软件公司进入药品营销领域。Roberts先生在马萨诸塞州波士顿的塔夫茨大学（Tufts University）获得计算机工程学士学位。
Evan Roberts has served as Phreesia, Inc.'s President, Provider Solutions since July 2025 and is a co founder of Phreesia. In this role, Mr. Roberts oversees Phreesia's Provider business, including Customer Solutions, Customer Operations, Sales and Sales Development. Mr. Roberts previously served as Chief Operating Officer from January 2019 to June 2025, where he spearheaded the creation of the Company's contracted software development teams, led Phreesia's acquisitions and established Phreesia's India operations. Since co founding Phreesia in January 2005, Mr. Roberts has held a series of senior leadership roles across the organization, including serving as the Company's first Chief Technology Officer and later leading Customer Solutions. Having touched every part of the business over two decades, Mr. Roberts remains deeply focused on building products and teams that make healthcare simpler for everyone. Mr. Roberts received his B.S. degree in Computer Engineering from Tufts University.- Evan Roberts自2019年1月起担任我们的首席运营官。罗伯茨先生曾于2012年1月至2019年1月担任客户解决方案Vice President，并于2005年1月成立至2012年1月担任首席技术官。在共同创立Phreesia之前，Roberts先生是Spotfire，Inc.的高级销售工程师，在那里他成功地领导了分析软件公司进入药品营销领域。Roberts先生在马萨诸塞州波士顿的塔夫茨大学（Tufts University）获得计算机工程学士学位。
- Evan Roberts has served as Phreesia, Inc.'s President, Provider Solutions since July 2025 and is a co founder of Phreesia. In this role, Mr. Roberts oversees Phreesia's Provider business, including Customer Solutions, Customer Operations, Sales and Sales Development. Mr. Roberts previously served as Chief Operating Officer from January 2019 to June 2025, where he spearheaded the creation of the Company's contracted software development teams, led Phreesia's acquisitions and established Phreesia's India operations. Since co founding Phreesia in January 2005, Mr. Roberts has held a series of senior leadership roles across the organization, including serving as the Company's first Chief Technology Officer and later leading Customer Solutions. Having touched every part of the business over two decades, Mr. Roberts remains deeply focused on building products and teams that make healthcare simpler for everyone. Mr. Roberts received his B.S. degree in Computer Engineering from Tufts University.
- David Linetsky
David Linetsky自2019年3月起担任生命科学高级副总裁，。他曾担任我们的Vice President、分析和见解（从2018年7月到2019年3月）、我们的Vice President、财务和分析（从2015年1月到2018年7月）、我们的分析主管（从2013年1月到2014年12月），以及我们的高级数学家（从2008年到2012年）。2008年之前，Linetsky从2005年到2008年担任Phreesia实习生和顾问。Linetsky先生在加拿大艾伯塔省埃德蒙顿的阿尔伯塔大学（University of Alberta）获得数学学士学位，并获得哲学硕士学位。纽约市立大学（City University of New York，New York）研究生中心数学和逻辑学位，在那里他也是数学和逻辑博士候选人。
David Linetsky has served as Phreesia, Inc.'s President, Network Solutions since July 2025. In this role, Mr. Linetsky is responsible for cultivating Phreesia's partnerships with life sciences companies, advocacy groups, government agencies and other organizations. Mr. Linetsky previously served as Phreesia, Inc.'s Senior Vice President, Network Solutions from March 2019 to June 2025, during which time he built and led the Company's Life Sciences organization and founded Phreesia's data science team. Since first joining Phreesia in 2005, Mr. Linetsky has held a series of leadership roles spanning finance, analytics and data science, contributing to the Company's growth from a startup to a publicly traded healthcare technology company. With roots in academic mathematics, Mr. Linetsky combines analytical rigor with a deep understanding of the healthcare ecosystem to drive the Company's network solutions strategy. Mr. Linetsky received his B.S. degree in Mathematics from the University of Alberta and his M.Phil. degree in Mathematics and Logic from the Graduate Center of the City University of New York, where he was also a Ph.D. candidate in Mathematics and Logic.- David Linetsky自2019年3月起担任生命科学高级副总裁，。他曾担任我们的Vice President、分析和见解（从2018年7月到2019年3月）、我们的Vice President、财务和分析（从2015年1月到2018年7月）、我们的分析主管（从2013年1月到2014年12月），以及我们的高级数学家（从2008年到2012年）。2008年之前，Linetsky从2005年到2008年担任Phreesia实习生和顾问。Linetsky先生在加拿大艾伯塔省埃德蒙顿的阿尔伯塔大学（University of Alberta）获得数学学士学位，并获得哲学硕士学位。纽约市立大学（City University of New York，New York）研究生中心数学和逻辑学位，在那里他也是数学和逻辑博士候选人。
- David Linetsky has served as Phreesia, Inc.'s President, Network Solutions since July 2025. In this role, Mr. Linetsky is responsible for cultivating Phreesia's partnerships with life sciences companies, advocacy groups, government agencies and other organizations. Mr. Linetsky previously served as Phreesia, Inc.'s Senior Vice President, Network Solutions from March 2019 to June 2025, during which time he built and led the Company's Life Sciences organization and founded Phreesia's data science team. Since first joining Phreesia in 2005, Mr. Linetsky has held a series of leadership roles spanning finance, analytics and data science, contributing to the Company's growth from a startup to a publicly traded healthcare technology company. With roots in academic mathematics, Mr. Linetsky combines analytical rigor with a deep understanding of the healthcare ecosystem to drive the Company's network solutions strategy. Mr. Linetsky received his B.S. degree in Mathematics from the University of Alberta and his M.Phil. degree in Mathematics and Logic from the Graduate Center of the City University of New York, where he was also a Ph.D. candidate in Mathematics and Logic.
- Amy Beth VanDuyn
Amy Beth VanDuyn自2019年3月起担任我们的人力资源高级副总裁。她曾于2010年4月至2019年3月担任我们的人力资源Vice President。任职Phreesia公司之前，Vanduyn女士曾担任许多行业的人力资源领导职务，包括软件即服务、酒店和公共关系。Vanduyn女士在密歇根州东兰辛的密歇根州立大学（Michigan State University）获得酒店业工商管理学士学位。
Amy Beth VanDuyn has served as Phreesia, Inc.'s Senior Vice President of Human Resources since March 2019 and has more than 20 years of human resources experience to Phreesia, where she is responsible for the design and implementation of all talent strategies, policies and processes across the Company. She previously served as Phreesia, Inc.'s Vice President of Human Resources from April 2010 until March 2019. Prior to joining Phreesia, Ms. VanDuyn worked in human resource leadership roles across many industries, including hospitality, SaaS and public relations, contributing to the growth and culture of companies at a variety of sizes and stages. Her passion lies in working closely with business leaders to define and implement talent strategies that align with their business goals, and creating environments where people can grow and excel in their careers. Ms. VanDuyn received her B.A. degree in Hospitality Business from Michigan State University.- Amy Beth VanDuyn自2019年3月起担任我们的人力资源高级副总裁。她曾于2010年4月至2019年3月担任我们的人力资源Vice President。任职Phreesia公司之前，Vanduyn女士曾担任许多行业的人力资源领导职务，包括软件即服务、酒店和公共关系。Vanduyn女士在密歇根州东兰辛的密歇根州立大学（Michigan State University）获得酒店业工商管理学士学位。
- Amy Beth VanDuyn has served as Phreesia, Inc.'s Senior Vice President of Human Resources since March 2019 and has more than 20 years of human resources experience to Phreesia, where she is responsible for the design and implementation of all talent strategies, policies and processes across the Company. She previously served as Phreesia, Inc.'s Vice President of Human Resources from April 2010 until March 2019. Prior to joining Phreesia, Ms. VanDuyn worked in human resource leadership roles across many industries, including hospitality, SaaS and public relations, contributing to the growth and culture of companies at a variety of sizes and stages. Her passion lies in working closely with business leaders to define and implement talent strategies that align with their business goals, and creating environments where people can grow and excel in their careers. Ms. VanDuyn received her B.A. degree in Hospitality Business from Michigan State University.
- Balaji Gandhi
Balaji Gandhi，自2023年3月起担任Phreesia, Inc.首席财务官。在此之前，他自2021年2月起担任Phreesia, Inc.投资者关系高级副总裁，并于2019年7月至2021年1月担任投资者关系副总裁。从2017年7月至2019年6月，甘地先生担任Madaket Inc.的首席财务官，该公司是一家基于云的医疗保健软件即服务公司。甘地先生在罗切斯特大学获得学士学位，并在乔治华盛顿大学获得卫生服务管理硕士学位，卫生政策分析。
Balaji Gandhi has served as Phreesia, Inc.'s Chief Financial Officer since March 2023. In this role, Mr. Gandhi oversees the Company's budgeting, forecasting, financial reporting, financial analysis, internal controls and investor relations. He previously served as Phreesia, Inc.'s SVP, Investor Relations from February 2021 to March 2023, having joined Phreesia in July 2019 as Vice President, Investor Relations in preparation for the Company's initial public offering. Prior to Phreesia, Mr. Gandhi served as Chief Financial Officer of Madaket Health, a cloud based healthcare software as a service company, and built his career across healthcare finance, investment research and corporate strategy. Mr. Gandhi's time on both the operating side and the capital markets side of healthcare gives him a distinctive perspective on connecting Phreesia's financial strategy to its mission of creating a better healthcare experience. Mr. Gandhi received his bachelor's degree from the University of Rochester and received his Master of Health Services Administration, Health Policy Analysis from The George Washington University.- Balaji Gandhi，自2023年3月起担任Phreesia, Inc.首席财务官。在此之前，他自2021年2月起担任Phreesia, Inc.投资者关系高级副总裁，并于2019年7月至2021年1月担任投资者关系副总裁。从2017年7月至2019年6月，甘地先生担任Madaket Inc.的首席财务官，该公司是一家基于云的医疗保健软件即服务公司。甘地先生在罗切斯特大学获得学士学位，并在乔治华盛顿大学获得卫生服务管理硕士学位，卫生政策分析。
- Balaji Gandhi has served as Phreesia, Inc.'s Chief Financial Officer since March 2023. In this role, Mr. Gandhi oversees the Company's budgeting, forecasting, financial reporting, financial analysis, internal controls and investor relations. He previously served as Phreesia, Inc.'s SVP, Investor Relations from February 2021 to March 2023, having joined Phreesia in July 2019 as Vice President, Investor Relations in preparation for the Company's initial public offering. Prior to Phreesia, Mr. Gandhi served as Chief Financial Officer of Madaket Health, a cloud based healthcare software as a service company, and built his career across healthcare finance, investment research and corporate strategy. Mr. Gandhi's time on both the operating side and the capital markets side of healthcare gives him a distinctive perspective on connecting Phreesia's financial strategy to its mission of creating a better healthcare experience. Mr. Gandhi received his bachelor's degree from the University of Rochester and received his Master of Health Services Administration, Health Policy Analysis from The George Washington University.
- Allison Hoffman
Allison Hoffman，女，自2013年8月以来担任本公司的副执行总裁、法律总顾问和公司秘书，她是于2012年12月加入该公司的。1999年6月-2012年9月期间在一家为法律和房地产行业提供专业新闻和信息咨询的主要供应商-ALM Media有限责任公司工作，2007年1月-2012年9月期间担任高级副总裁、首席法务官以及秘书；在2001年8月-2006年12月期间担任副总裁、法律总顾问和秘书职务；以及在1999年6月-2001年7月期间担任助理法律总顾问。1995年-1999年是Skadden、 Arps、Slate、Meagher和Flom LLP. 公司财政部门的助理；自2012年以来她还在Network-1 Technologies股份有限公司 （OTC Bulletin Board： NTIP）董事会任职，以及是薪酬委员会主席和审计委员会的成员。
Allison Hoffman has been a member of Network 1 Technologies, Inc.'s Board of Directors since December 2012 and serves as Chair of Network 1 Technologies, Inc.'s Audit Committee and Compensation Committee. Ms. Hoffman is also a member of Network 1 Technologies, Inc.'s Nominating and Corporate Governance Committee. Since August 2020, Ms. Hoffman has served as General Counsel of Phreesia, Inc. (NYSE:PHR), a leading provider of software solutions that healthcare organizations use to manage the patient intake process.- Allison Hoffman，女，自2013年8月以来担任本公司的副执行总裁、法律总顾问和公司秘书，她是于2012年12月加入该公司的。1999年6月-2012年9月期间在一家为法律和房地产行业提供专业新闻和信息咨询的主要供应商-ALM Media有限责任公司工作，2007年1月-2012年9月期间担任高级副总裁、首席法务官以及秘书；在2001年8月-2006年12月期间担任副总裁、法律总顾问和秘书职务；以及在1999年6月-2001年7月期间担任助理法律总顾问。1995年-1999年是Skadden、 Arps、Slate、Meagher和Flom LLP. 公司财政部门的助理；自2012年以来她还在Network-1 Technologies股份有限公司 （OTC Bulletin Board： NTIP）董事会任职，以及是薪酬委员会主席和审计委员会的成员。
- Allison Hoffman has been a member of Network 1 Technologies, Inc.'s Board of Directors since December 2012 and serves as Chair of Network 1 Technologies, Inc.'s Audit Committee and Compensation Committee. Ms. Hoffman is also a member of Network 1 Technologies, Inc.'s Nominating and Corporate Governance Committee. Since August 2020, Ms. Hoffman has served as General Counsel of Phreesia, Inc. (NYSE:PHR), a leading provider of software solutions that healthcare organizations use to manage the patient intake process.